Kayyem Jon Faiz bought 5,000 Inhibrx Biosciences shares at $100 each. For investors tracking insider ownership, the purchase leaves him with 429,360 shares, while the transaction represents about 1.2% of his resulting holding.

Key Highlights

  • Kayyem Jon Faiz’s purchase represented about 1.2% of his resulting Inhibrx Biosciences shareholding.
  • Transaction code P identifies the September 16 purchase as an open-market transaction.
  • Faiz’s reported position after the purchase was 429,360 Inhibrx Biosciences shares.

$100 Per-Share Purchase

Inhibrx Biosciences, Inc. (NASDAQ: INBX) is a biotechnology company. The shares changed hands at $100 per share. The purchase date was 16 September 2026.

Resulting Holding Reaches 429,360 Shares Faiz’s reported ownership after the transaction was 429,360 shares.

The purchase represented about 1.2% of that resulting holding. That percentage is measured against Faiz’s post-transaction position in Inhibrx Biosciences, Inc. The stated ownership figure covers his shares after the purchase.